ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Yusuf AA, et al. Kidney disease and APOL1. Hum Mol Genet 2021; 30:R129–R137. doi: 10.1093/hmg/ddab024
-
2.
ASN Steering Committee Workgroup Members. Kidney Health Initiative. Current project. Roadmap to increase disease awareness and clinical trial participation of people carrying high-risk genetic variants of APOL1-associated nephropathy. Accessed March 7, 2023. https://khi.asn-online.org/projects/project.aspx?ID=91
-
3.
US Centers for Disease Control and Prevention. The U.S. Public Health Service Syphilis Study at Tuskegee. https://www.cdc.gov/tuskegee/timeline.htm
-
4.
Henrietta Lacks: Science must right a historical wrong. Nature 2020; 585:7. doi: 10.1038/d41586-020-02494-z
-
5.
Nicholas SB, Cervantes L; Clinical Care & Innovation Workgroup of the American Society of Nephrology Health Care Justice Committee. Health care equity and justice scorecard to increase diversity in clinical trial recruitment and retention. J Am Soc Nephrol 2022; 33:1652–1655. doi: 10.1681/ASN.2022040427
-
6.
Clinicaltrials.gov. Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease (JUSTICE). ClinicalTrials.gov Identifier: NCT05237388
Mapping a Path to Improved APOL1 Kidney Disease Awareness, Trial Participation, and Care
Bridget M. Kuehn
Bridget M. Kuehn
Search for other papers by Bridget M. Kuehn in
Current site
Google Scholar
PubMed
Search for other papers by Bridget M. Kuehn in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory
Powered by PubFactory